NM_024426.6(WT1):c.152C>A (p.Ala51Asp) AND Wilms tumor 1

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 15, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004013523.2

Allele description [Variation Report for NM_024426.6(WT1):c.152C>A (p.Ala51Asp)]

NM_024426.6(WT1):c.152C>A (p.Ala51Asp)

Genes:

WT1:WT1 transcription factor [Gene - OMIM - HGNC]
LOC107982234:WT1/WT1-AS bi-directional promoter region [Gene]

Variant type:

single nucleotide variant

Cytogenetic location:

11p13

Genomic location:

Preferred name:

NM_024426.6(WT1):c.152C>A (p.Ala51Asp)

HGVS:

NC_000011.10:g.32435209G>T
NG_009272.1:g.5333C>A
NG_050766.1:g.4462G>T
NG_050766.2:g.5141G>T
NM_000378.6:c.152C>A
NM_001407044.1:c.152C>A
NM_001407045.1:c.152C>A
NM_001407046.1:c.152C>A
NM_001407047.1:c.152C>A
NM_001407048.1:c.152C>A
NM_001407049.1:c.152C>A
NM_001407050.1:c.152C>A
NM_001429031.1:c.-68C>A
NM_001429032.1:c.-68C>A
NM_001429033.1:c.-68C>A
NM_001429034.1:c.-68C>A
NM_024424.5:c.152C>A
NM_024425.2:c.137C>A
NM_024426.6:c.152C>AMANE SELECT
NP_000369.4:p.Ala51Asp
NP_001393973.1:p.Ala51Asp
NP_001393974.1:p.Ala51Asp
NP_001393975.1:p.Ala51Asp
NP_001393976.1:p.Ala51Asp
NP_001393977.1:p.Ala51Asp
NP_001393978.1:p.Ala51Asp
NP_001393979.1:p.Ala51Asp
NP_077742.3:p.Ala51Asp
NP_077743.2:p.Ala46Asp
NP_077744.3:p.Ala46Asp
NP_077744.4:p.Ala51Asp
LRG_525t1:c.137C>A
LRG_525:g.5333C>A
LRG_525p1:p.Ala46Asp
NC_000011.9:g.32456755G>T
NM_024426.3:c.137C>A
NR_160306.1:n.331C>A
NR_176266.1:n.331C>A

Protein change:

A46D

Molecular consequence:

NM_000378.6:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407044.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407045.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407046.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407047.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407048.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407049.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407050.1:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_024424.5:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_024425.2:c.137C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_024426.6:c.152C>A - missense variant - [Sequence Ontology: SO:0001583]
NR_160306.1:n.331C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176266.1:n.331C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Observations:

Condition(s)

Name:: Wilms tumor 1 (WT1)
Synonyms:: Wilms tumor, somatic
Identifiers:: MONDO: MONDO:0008679; MedGen: CN033288; Orphanet: 654; OMIM: 194070

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004827249	All of Us Research Program, National Institutes of Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain Significance (Aug 15, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004827249

All of Us Research Program, National Institutes of Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain Significance
(Aug 15, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	2	not provided	not provided	108544	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004827249.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	2	not provided	not provided	clinical testing	PubMed (1)

Description

This missense variant replaces alanine with aspartic acid at codon 46 of the WT1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with WT1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	108544	not provided	not provided		2	not provided	not provided	not provided

Last Updated: Jun 9, 2024

ClinVar

Relating variation to medicine